Despite serious question marks around RNA technology, another research and pilot facility is being built in New South Wales.
Instead of politicians finally acknowledging there are serious safety concerns around mRNA ‘vaccines’ and slamming on the brakes in the interest of public safety, it’s heads down and full steam ahead with a $96m research and pilot facility already under construction on the campus of Macquarie University in Sydney, expected to be completed in 2026.
The facility is proudly sponsored by the NSW government. Aurora Biosynthetics, a subsidiary of US-based Myeloid Therapeutics, will operate the facility, developing and testing a wide range of RNA products, overseen by RNA Australia Limited, a joint venture consisting of the NSW Government and four universities (including Macquarie University, the Australian National University, and possibly the University of New South Wales and the Sydney University), with the NSW government already having contributed $10m on the entity, and a further $119m being spent on the technology over 10 years.
